Literature DB >> 25574679

Incidental endometrial carcinoma diagnosed at first trimester pregnancy loss: a case report.

Lana Saciragic1, Christopher G Ball1, Shahidul Islam1, Michael Fung-Kee-Fung1.   

Abstract

BACKGROUND: All cases reported to date of endometrioid endometrial adenocarcinoma (EEA) associated with pregnancy have been treated surgically or medically. We describe a case of EEA in pregnancy that was managed expectantly, allowing for observation of the natural course of the disease. CASE: A 36-year-old woman, gravida 2 para 1, presented at eight weeks of pregnancy with heavy vaginal bleeding. Ultrasound assessment confirmed a missed abortion, and the patient underwent dilatation and curettage. Tissue pathology primarily suggested grade 1 EEA. The patient chose expectant management. Eight months later, she returned with vaginal bleeding. Hysterectomy was performed and the hysterectomy specimen showed FIGO grade 1 stage 1A EEA.
CONCLUSION: Treating EEA associated with pregnancy is challenging. Our experience in the case described here suggests that expectant management should not be undertaken due to a high risk of recurrence.

Entities:  

Keywords:  abortion; endometrial carcinoma; fertility sparing; products of conception

Mesh:

Year:  2014        PMID: 25574679     DOI: 10.1016/S1701-2163(15)30415-1

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  2 in total

Review 1.  Endometrial carcinoma in a gravid uterus: a case report and literature review.

Authors:  Mayu Shiomi; Shinya Matsuzaki; Eiji Kobayashi; Takeya Hara; Satoshi Nakagawa; Tsuyoshi Takiuchi; Kazuya Mimura; Yutaka Ueda; Takuji Tomimatsu; Tadashi Kimura
Journal:  BMC Pregnancy Childbirth       Date:  2019-11-20       Impact factor: 3.007

2.  Pathological examination of a placenta leading to the diagnosis of endometrial carcinoma: A case report.

Authors:  Takaaki Maeda; Masato Nishimura; Eishi Sogawa; Takashi Kaji; Minoru Irahara; Takeshi Iwasa
Journal:  Mol Clin Oncol       Date:  2021-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.